(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
Live Chart Being Loaded With Signals
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States...
Stats | |
---|---|
Today's Volume | 326 072 |
Average Volume | 3.86M |
Market Cap | 17.07M |
EPS | $0 ( 2024-05-13 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.130 |
ATR14 | $0.0120 (0.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-09 | Brenner Martin | Buy | 147 300 | Stock Option (right to buy) |
2024-05-09 | Brenner Martin | Buy | 110 000 | Stock Option (right to buy) |
2024-05-09 | Duran Felipe | Buy | 90 000 | Stock Option (right to buy) |
2024-04-25 | Duran Felipe | Buy | 35 800 | Stock Option (right to buy) |
2023-11-01 | Brenner Martin | Sell | 4 881 | Common Stock |
INSIDER POWER |
---|
88.07 |
Last 90 transactions |
Buy: 50 268 524 | Sell: 29 398 433 |
Volume Correlation
Ibio Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ibio Inc Correlation - Currency/Commodity
Ibio Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.11M (0.00 %) |
EPS: | $-47.87 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.11M (0.00 %) |
EPS: | $-47.87 |
FY | 2022 |
Revenue: | $2.38M |
Gross Profit: | $2.17M (90.94 %) |
EPS: | $-2 924.26 |
FY | 2021 |
Revenue: | $2.37M |
Gross Profit: | $909 000 (38.34 %) |
EPS: | $-2.97 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Ibio Inc
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators